Duchenne Muscular Dystrophy Treatment Market: How Is Exon-Skipping Antisense Therapy Creating Disease-Modifying Treatment Foundation?
Exon-skipping antisense therapy creating foundation — Duchenne muscular dystrophy (DMD) treatment's transformation through antisense oligonucleotide exon-skipping approaches (eteplirsen, golodirsen, viltolarsen) — enabling truncated dystrophin protein restoration in DMD patients carrying specific dystrophin mutations amenable to exon-skipping — establishing disease-modifying...
0 Yorumlar 0 hisse senetleri 17 Views 0 önizleme